Isomalto-oligosaccharides, usually shortened to IMOs, are short chains of glucose molecules linked together in a way that makes them harder for your body to break down than regular sugar or starch. They occur naturally in small amounts in fermented foods like miso, sake, and honey, and they’re manufactured commercially from starch for use as a mild sweetener and bulking agent in protein bars, fiber supplements, and other packaged foods. Whether they’re truly “safe” isn’t in serious dispute; European food safety authorities have evaluated them up to very high daily doses without raising red flags. The more interesting question, and the one that has shifted over the past decade, is whether IMOs actually do what many product labels imply they do.
What Makes IMOs Different from Regular Sugar
Table sugar (sucrose) and the glucose chains in starch are held together primarily by a type of bond called an alpha-1,4 linkage. Your digestive enzymes are extremely good at snipping those bonds apart. IMOs feature a different connection between their glucose units: an alpha-1,6 linkage. That single difference in geometry is the whole story. The 1,6 bond is angled differently, and your small intestine’s enzymes work more slowly on it. NMR analysis of commercial IMO preparations shows that about half of the bonds are the alpha-1,6 type, with the rest being the conventional alpha-1,4 bonds and some branching structures.1PubMed Central. Taste Perception of Sugar-Free Isomaltooligosaccharides Purer preparations can push the alpha-1,6 proportion to around 75%, which matters because the higher that ratio, the less digestible the product becomes.
In terms of chain length, IMOs typically range from two to about ten glucose units, though some production methods can push this up to fourteen units.2PubMed Central. Production of a Series of Long-Chain Isomaltooligosaccharides from Maltose by Bacillus subtilis AP-1 and Associated Prebiotic Properties Longer chains tend to resist digestion more effectively. The shortest member, isomaltose (just two glucose units), is easier to digest than longer-chain versions, which is why the composition of a given IMO product influences how it behaves in your body.
How IMOs Are Manufactured
Almost all commercial IMOs start as plain starch, typically from corn, tapioca, or potatoes. The production involves a multi-step enzyme process. First, the starch is liquefied and broken into shorter maltose-like fragments using amylase enzymes. Then a key enzyme called alpha-transglucosidase rearranges those fragments, converting the standard alpha-1,4 bonds into the alpha-1,6 bonds that define IMOs. One research group developed an enzyme cocktail approach using pullulanase, alpha-amylase, beta-amylase, and alpha-transglucosidase working simultaneously, achieving roughly 49% IMO content after 13 hours of reaction time.3Electronic Journal of Biotechnology. Highly efficient enzymatic preparation of isomalto-oligosaccharides from starch using an enzyme cocktail
Researchers have also explored using potato peel waste as a starch source, cloning the transglucosidase gene from the fungus Aspergillus niger and expressing it in bacteria for large-scale production.4PubMed Central. Immobilization of α-transglucosidase on silica-coated magnetic nanoparticles and its application for production of isomaltooligosaccharide from the potato peel This matters to you mainly because it explains why IMOs are cheap and abundant compared to other specialty fibers like fructo-oligosaccharides. Starch is one of the least expensive raw materials in the food industry, and the enzymatic conversion is straightforward. That cost advantage is a big reason IMOs became so popular in protein bars and “high fiber” snack foods over the past decade.
The Fiber Controversy
For years, IMOs were marketed in the United States and elsewhere as dietary fiber. The logic seemed sound: the alpha-1,6 bonds should resist human digestive enzymes, allowing the molecules to pass into the colon intact, where gut bacteria could ferment them. That was the prevailing view through the early 2010s, and it’s why so many protein bars and low-carb products counted IMOs toward their fiber totals.
Then the picture changed. A 2022 study tested how mammalian enzymes actually handle IMOs and found something that upended the earlier consensus. When researchers exposed various IMO preparations to the human sucrase-isomaltase enzyme complex (the enzyme that sits on the surface of your small intestinal cells), those enzymes fully broke down the IMOs into glucose. They did it slowly compared to regular starch, but they did it completely.5PubMed. New insights suggest isomaltooligosaccharides are slowly digestible carbohydrates, rather than dietary fibers, at constitutive mammalian α-glucosidase levels The earlier studies showing IMOs resisted digestion had used a fungal enzyme (amyloglucosidase) that happens to be very poor at breaking alpha-1,6 bonds. The mammalian enzyme your gut actually uses handles them just fine, just at a slower pace.
The practical upshot is that standard commercial IMOs behave more like slowly digestible carbohydrates than like true dietary fiber. They do get absorbed, they do contribute calories, and they do raise blood sugar. The U.S. Food and Drug Administration ultimately did not include IMOs on its list of approved dietary fibers for nutrition labeling, which prompted many product reformulations. Some manufacturers switched to other fiber sources; others quietly adjusted their labels.
There is a nuance worth noting. Longer-chain IMOs with a higher proportion of alpha-1,6 bonds appear to resist digestion more effectively than the short-chain, mixed-linkage commercial products. The digestibility problem is most acute for the cheaper, lower-purity IMO syrups that dominated the market. A preparation that is genuinely rich in long-chain, high-alpha-1,6 material may still behave partly as a prebiotic fiber, though the evidence base for those specific products is thinner.
What IMOs Do to Your Blood Sugar
Given that most commercial IMOs are digested and absorbed (slowly), you’d expect them to raise blood glucose. And they do. In a trial comparing IMO syrup to dextrose (pure glucose) in healthy adults, blood glucose and insulin responses were not significantly different over two hours for either of two IMO formulations tested.6PubMed Central. Gastrointestinal Tolerance and Glycemic Response of Isomaltooligosaccharides in Healthy Adults There was a modest trend toward lower glucose area-under-the-curve for IMO over four hours, suggesting the absorption was stretched out somewhat, but the difference was small and mostly didn’t reach statistical significance.
A separate study in young adults found that IMO produced significantly higher blood glucose and insulin spikes at 30 minutes compared to soluble corn fiber, which is a genuinely non-digestible fiber.7Journal of Metabolic Health. The effects of soluble corn fibre and isomaltooligosacharides on blood glucose, insulin, digestion and fermentation in healthy young males and females The soluble corn fiber behaved like a placebo in terms of blood sugar response; the IMO did not.
Another trial went further, calculating a relative glycemic index for IMO. When 20 grams of IMO was consumed, it raised plasma glucose by about 2.8 mmol/L and insulin by roughly 1,000 pg/mL at 30 minutes, producing a glycemic glucose equivalent of 1.35 grams and a relative glycemic index of 27.8ScienceDirect. Ingestion of isomalto-oligosaccharides stimulates insulin and incretin hormone secretion in healthy adults That study also found that IMO stimulated the gut hormones GLP-1 and GIP at levels similar to pure dextrose, which reinforces the point that your body treats IMOs much more like a digestible carbohydrate than like an inert fiber.
If you’re managing blood sugar for health reasons, the takeaway is straightforward: do not treat IMO-containing products as “free” or fiber-only. They contribute real glucose and trigger a real insulin response. The effect is somewhat slower and flatter than pure sugar, which is modestly better, but it’s nowhere near what a true prebiotic fiber would do.
Safety and Tolerability
On the basic question of whether IMOs are safe to eat, the evidence is reassuring. The European Food Safety Authority (EFSA) published an evaluation in 2024 covering IMO as a novel food ingredient. They examined the manufacturing process, composition, and toxicological data, and concluded that IMO does not present safety concerns under the proposed conditions of use. A tolerability study in adult volunteers tested doses up to 120 grams per day, which is an enormous amount, and found it tolerable.9PubMed Central. Extension of use of isomalto-oligosaccharide as a novel food pursuant to Regulation (EU) 2015/2283 EFSA noted that conservative intake estimates under proposed uses could reach up to 142 grams per day in adolescents at the high end, which slightly exceeds the tested dose, but the panel still did not flag safety concerns given the nature and composition of the ingredient.
For context, 120 grams per day is far more than anyone would realistically consume from food products. A typical protein bar contains 10 to 15 grams of IMO. You’d need to eat eight to twelve bars a day to approach the tested ceiling. At normal consumption levels, gastrointestinal side effects like bloating or gas are generally mild. IMOs are considerably better tolerated than some other oligosaccharides and sugar alcohols. You’re unlikely to experience the dramatic laxative effect that can come with large doses of sugar alcohols like sorbitol or maltitol.
That said, “safe to eat” and “does what the label says” are different questions. The safety finding means IMOs won’t harm you. It doesn’t validate any particular health claim printed on a product. And since most commercial IMOs are largely digestible, the gap between marketing and reality can be wide.
Do IMOs Actually Feed Your Gut Bacteria?
The prebiotic question is where the science gets genuinely complicated, because the answer depends on which IMOs you’re talking about. Truly indigestible IMOs, meaning longer-chain molecules with a high proportion of alpha-1,6 linkages, do reach the colon and get fermented by gut bacteria. When colonic bacteria metabolize these molecules, they produce short-chain fatty acids, the same beneficial compounds generated by other well-established prebiotics.10PubMed Central. Current Research on the Role of Isomaltooligosaccharides in Gastrointestinal Health and Metabolic Diseases In vitro fermentation experiments have confirmed that IMOs produce more short-chain fatty acids than blank cultures, though the effect can be diminished when certain plant compounds like tannic acid are present.11PubMed Central. Tannic acid delayed dietary fiber fermentation: dual mechanisms of enzyme inhibition and microbial community dynamics
Animal studies have shown shifts in gut microbial communities with IMO supplementation. In one study with sows, IMO feeding increased the relative abundance of several bacterial genera, including a non-significant trend toward more Bifidobacterium, a genus widely considered beneficial.12PubMed Central. Effects of Dietary Isomaltooligosaccharide Levels on the Gut Microbiota, Immune Function of Sows, and the Diarrhea Rate of Their Offspring The Bifidobacterium increase didn’t reach statistical significance in that study, which is worth noting because the ability to boost Bifidobacterium counts is often the headline claim made for IMO prebiotics. The evidence is suggestive but not as robust as what exists for fructo-oligosaccharides or galacto-oligosaccharides, which are more thoroughly validated prebiotics.
The catch, as described earlier, is that the cheaper commercial IMO products likely don’t deliver much material to the colon in the first place. If your small intestine digests and absorbs most of the IMO before it reaches your large intestine, there’s not much left for bacteria to ferment. The prebiotic potential of IMOs is real in principle but may be largely unrealized in the products most consumers actually buy.
IMOs and Immune Function
A smaller body of research has looked at whether IMOs influence immune responses beyond just feeding gut bacteria. In a mouse study, animals fed a diet containing 20% IMO for four weeks showed higher fecal levels of the antibody IgA and greater numbers of Lactobacillus bacteria in their guts compared to controls. Their intestinal immune cells also showed a shift toward a type of immune response associated with fighting intracellular pathogens.13The Journal of Nutrition. Isomalto-Oligosaccharides Polarize Th1-Like Responses in Intestinal and Systemic Immunity in Mice
These findings are interesting but come with the usual caveat that mouse immune systems don’t map neatly onto human ones, and a 20% dietary concentration is vastly higher than any realistic human intake. No human trials have demonstrated clinically meaningful immune benefits from IMO consumption. The immune angle remains a plausible mechanism worth studying rather than a selling point consumers should rely on.
Reading Labels and Making Choices
If you’re picking up a product that lists isomalto-oligosaccharides, “IMO syrup,” or “IMO fiber” on the label, here’s what’s useful to know. First, check whether the product counts IMOs toward its fiber total. In the U.S., this is no longer considered appropriate for standard commercial IMOs, but some older formulations or imported products may still do it. If you see suspiciously high fiber numbers on a protein bar or snack, IMOs might be the explanation.
Second, treat the calories as real. For practical purposes, IMOs contribute roughly the same caloric load as other digestible carbohydrates, though the energy delivery is slower. If you’re counting carbohydrates or calories, IMOs should be counted. The “net carb” calculations that some products use to subtract IMOs from the total are based on the outdated assumption that IMOs pass through undigested.
Third, if your goal is genuinely prebiotic fiber, other options have stronger evidence. Inulin, fructo-oligosaccharides, and psyllium all have more extensive human trial data supporting their effects on gut bacteria and bowel function. IMOs aren’t harmful, but they’re not the best tool for that job if you have alternatives.
Why Purity and Chain Length Matter More Than the Name
One reason the IMO literature can seem contradictory is that “IMO” is not a single molecule. It’s a category covering a spectrum of products with different chain lengths, different ratios of alpha-1,6 to alpha-1,4 bonds, and varying amounts of simple sugars mixed in. A highly purified, long-chain IMO preparation might genuinely resist small intestinal digestion and deliver prebiotic benefits. A cheap IMO syrup that’s half maltose and short-chain fragments will behave much more like sugar.
Researchers have begun distinguishing between these preparations more carefully. Some newer products marketed as “high-purity IMO” or “long-chain IMO” aim to address the digestibility criticism by concentrating the longer, more resistant molecules. Whether these reformulated products live up to their fiber claims awaits more human trial data. The science has caught up to the marketing problem, but the marketplace hasn’t fully sorted itself out yet.
For now, the most honest characterization of standard commercial IMOs is that they are a mildly sweet, slowly digestible carbohydrate with modest and uncertain prebiotic properties. They are safe to consume in any amount you’d realistically encounter in food. They are not a meaningful source of dietary fiber in the way that most consumers understand that term, and products that rely heavily on IMOs for their “high fiber” or “low net carb” branding are stretching the truth, even if they’re not technically lying in every jurisdiction.